Sensex and Nifty Performance Overview

After opening 657.85 points higher, the Sensex maintained its upward momentum throughout the session, closing comfortably above its 50-day moving average (DMA). However, the 50DMA remains below the 200DMA, signalling a medium-term consolidation phase despite the current bullishness. The Nifty mirrored this strength, buoyed by sectoral leaders and broad-based buying.

Large caps were the primary drivers of today’s rally, with the Sensex gaining 1.07%. Mid caps traded largely flat, reflecting cautious investor sentiment ahead of key corporate earnings scheduled for 30 Jul 2026, including Tata Steel, Vedanta, and Torrent Pharma. Small caps outperformed moderately, with the S&P BSE 500 Smallcap Index rising 1.16%, while the BSE 100 and S&P BSE 150 Midcap indices advanced 0.94% and 0.64% respectively.

Sectoral Trends: IT and Pharma Shine

Out of 38 sectors tracked, 28 advanced while 10 declined, underscoring broad market participation. The NIFTY IT sector emerged as the top gainer, surging 2.43% on strong buying interest in technology stocks. The pharmaceutical and healthcare segments also impressed, with NIFTY PHARMA, S&P BSE Healthcare, and S&P BSE Consumer Durables hitting new 52-week highs, reflecting optimism around earnings and sectoral growth prospects.

Conversely, the NIFTY Realty sector lagged, declining 0.50%, weighed down by profit-booking and subdued demand outlook. This divergence highlights the selective nature of the rally, with investors favouring defensive and growth-oriented sectors amid mixed macroeconomic signals.

Top Gainers and Losers Across Market Caps

Among large caps, Divi's Laboratories led the gainers with a 4.50% rise, benefiting from sector tailwinds and positive sentiment around pharmaceutical exports. In the mid-cap space, Swiggy outperformed with a 7.70% jump, reflecting renewed investor confidence in the food delivery and tech-enabled services sector.

Small caps witnessed notable gains from Kaynes Technology, which soared 12.79%, followed by Firstsource Solutions and Paradeep Phosphates, which rose 11.72% and 11.67% respectively. These sharp moves indicate pockets of strong buying interest in select small-cap stocks.

On the downside, Adani Ports was the top large-cap loser, slipping 2.34% amid profit-taking. Mid-cap laggards included Phoenix Mills and City Union Bank, which declined 5.49% and 5.41% respectively, reflecting sector-specific pressures and cautious investor stance. Sumitomo Chemical also fell 5.25%, adding to the small-cap weakness in certain pockets.

Market Breadth and Investor Activity

The market breadth was strongly positive, with an advance-decline ratio of 380 advances to 118 declines across the BSE 500, translating to a robust 3.22 times more advancing stocks. This breadth confirms the broad-based nature of the rally, extending beyond a handful of large-cap names.

Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) remained active participants, with FIIs continuing to inject capital into select sectors, particularly IT and Pharma, while DIIs maintained steady buying across large and mid caps. This balanced participation helped sustain the upward momentum despite some profit-booking in realty and commodity-linked stocks.

Global Cues and Outlook

Positive global cues supported the domestic market’s advance. Major international indices showed resilience amid easing geopolitical tensions and encouraging economic data from the US and Europe. The global technology sector’s strength also bolstered sentiment for Indian IT stocks, which are closely linked to overseas demand.

However, investors remain cautious ahead of upcoming corporate earnings, especially from heavyweight companies like Tata Steel, Vedanta, and Torrent Pharma, scheduled to report on 30 Jul 2026. These results are expected to provide further clarity on sectoral earnings trends and guide market direction in the near term.

Technical Indicators and Moving Averages

The Sensex’s current position above its 50DMA is a positive technical signal, suggesting short-term strength. However, the fact that the 50DMA remains below the 200DMA indicates that the market is still in a broader consolidation phase, and investors should watch for confirmation of a sustained uptrend.

Sectoral indices such as NIFTY PHARMA and S&P BSE Healthcare reaching new 52-week highs further reinforce the bullish undertone in defensive and growth sectors. Meanwhile, the subdued performance of the Realty sector highlights the uneven recovery across segments.

Investor Takeaway

Overall, the market’s strong breadth, sectoral leadership from IT and Pharma, and positive global environment provide a constructive backdrop for investors. However, selective stock picking remains crucial given the mixed performance in mid and small caps and the upcoming earnings season that could introduce volatility.

Investors should monitor key technical levels and sectoral trends closely, while keeping an eye on foreign and domestic institutional flows that continue to influence market direction. The current rally offers opportunities, particularly in large caps and high-quality mid caps, but caution is warranted in more volatile small-cap segments.

Upcoming Corporate Earnings to Watch

Market participants are eagerly awaiting the quarterly results of Tata Steel, Vedanta, and Torrent Pharma on 30 Jul 2026. These companies are bellwethers in their respective sectors and their performance will likely set the tone for the market’s next phase. Strong earnings could reinforce the current bullish momentum, while any disappointments may trigger sector-specific corrections.

Summary

In summary, the Indian equity market demonstrated resilience and broad-based strength on 29 Jul 2026, with the Sensex advancing over 800 points. Sectoral leadership from IT and Pharma, coupled with positive global cues and healthy market breadth, supported the rally. While mid caps traded flat and small caps showed selective strength, investors remain watchful ahead of key earnings announcements. The technical setup suggests cautious optimism, favouring quality stocks and sectors with robust fundamentals.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →